← Leaderboards
Michael Patrick Murphy
Indiana University Indianapolis
$4,654,100
Attributed
$5,815,752
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,815,752 · 3
VA$0 · 2
By mechanism
UM1$2,999,467 · 1
R01$2,816,285 · 2
I01$0 · 1
IS1$0 · 1
Top collaborators
- Keith Leonard March5 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- T. George Hornby$5,807,398
- Brian H. Johnstone$1,471,193
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTissuesAllogenicRandomizedCessation Of LifeDesignCell TherapyAutologousIschemiaPeripheral Arterial DiseasePlacebosPerfusionClinical TrialsAmputationBone MarrowPainRestLimb StructureOperative Surgical ProceduresFutureMorbidity - Disease RateDoseCostMuscle
Grant awards (19)
Human Vertebral Body Mesenchymal Stromal Cells from Organ Donors For Limb Preservation in a Murine Model of Diabetic Hindlimb Ischemia$510,169
R01 · FY2025 · HL · contact PI
Human Vertebral Body Mesenchymal Stromal Cells from Organ Donors For Limb Preservation in a Murine Model of Diabetic Hindlimb Ischemia$478,270
R01 · FY2024 · HL · contact PI
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm$0
I01 · FY2021 · VA · contact PI
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm$0
I01 · FY2020 · VA · contact PI
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation$397,744
R01 · FY2019 · HL · contact PI
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm$0
I01 · FY2019 · VA · contact PI
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation$454,582
R01 · FY2018 · HL · contact PI
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease$149,088
UM1 · FY2018 · HL · contact PI
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm$0
I01 · FY2018 · VA · contact PI
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease$527,074
UM1 · FY2017 · HL · contact PI
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation$457,720
R01 · FY2017 · HL · contact PI
Mesenchymal stem cells induce regulatory T cells in patients with aortic aneurysm$0
I01 · FY2017 · VA · contact PI
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation$517,800
R01 · FY2016 · HL · contact PI
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease$514,474
UM1 · FY2016 · HL · contact PI
ShEEP Request for 3DBioFactory, regenHU Biosystem Architects$0
IS1 · FY2016 · VA · contact PI
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease$206,758
UM1 · FY2015 · HL · contact PI
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease$531,086
UM1 · FY2014 · HL · contact PI
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease$515,656
UM1 · FY2013 · HL · contact PI
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease$555,331
UM1 · FY2012 · HL · contact PI